Bicara Therapeutics, Inc. (BCAX)
16.42
-0.41
(-2.44%)
USD |
NASDAQ |
Jan 02, 11:43
Bicara Therapeutics Price: 16.42 for Jan. 2, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pfizer Inc. | 25.20 |
| Oncotelic Therapeutics, Inc. | 0.079 |
| Dogwood Therapeutics, Inc. | 4.08 |
| CEL-SCI Corp. | 5.20 |
| AIM ImmunoTech, Inc. | 1.14 |
Price Related Metrics
| PEG Ratio | -0.0708 |
| Price to Book Value | 2.233 |
| Earnings Yield | -13.58% |
| Market Cap | 899.52M |
| PEGY Ratio | -0.0708 |